Santosh Kumar

TL;DR: It is hypothesize that SARS-CoV-2 host cell entry receptor—ACE2 based mechanism in GI tissue may be involved in COVID-19 in the pathogenesis of digestive symptoms, in increased diabetic complications, and in disease recurrence.

TL;DR: A review of the progress made since the commencement of the COVID-19 pandemic can be found in this article, where the authors narrate the progress in the human body, including virus-host interactions, pulmonary and other systemic manifestations, immunological dysregulations, complications, host-specific vulnerability, and long-term health consequences in the survivors.

TL;DR: Five compounds with predicted lysosomotropic activity showed antiviral activity comparable to ACV during lytic herpes simplex virus type 1 (HSV-1) infections, reduced viral DNA copy number, and reduced selected HSV- 1 protein levels; these compounds also inhibited the reactivation of 'quiescent' HSv-1 infection established in iPSC-neurons, but did not inhibit viral entry into host cells.

TL;DR: It is proposed that a SARS-CoV-2 binding with ACE2 mediates dysregulation of the sodium dependent nutrient transporters and hence may be a plausible basis for the digestive symptoms in COVID-19 patients.

TL;DR: In this paper, a study was conducted in a cotton spinning mill of Karachi in June 2006 to identify byssinosis in cotton mill workers, probable associations of disease with factors such as different work areas, safety gadget usage and overtime and to ascertain proportions of byssinsosis to accidental injuries.